Search
Now showing items 1-1 of 1
Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed.
(University of Nairobi, 2012-07)
Late presentation is common among African HIV-1-infected infants. Incidence and correlates of mortality were examined in 99 infants with HIV-1 diagnosis by 5 months of age. Twelve-month survival was 66.8% (95% confidence ...